Skip to main content

CABA research · 13F holders by reporting quarter

Cabaletta Bio, Inc. (CABA): 13F holders, 2026Q2

The largest share positions in CABA that the managers Kresmion follows reported on Form 13F for 2026Q2, as filed. The current quarter, the company's SEC filings and its recent events are on the CABA research page.

CABA positions held by the managers we follow (2026Q2)

What the managers we follow bought and sold in Q2 2026

Manager / securityMarket value% of reported value
CITADEL ADVISORS LLC FundCUSIP 12674W109 · 2026Q2$11M0.01%
MILLENNIUM MANAGEMENT LLC FundCUSIP 12674W109 · 2026Q2$6.4M0.00%
RENAISSANCE TECHNOLOGIES LLC FundCUSIP 12674W109 · 2026Q2$4.8M0.01%
TWO SIGMA INVESTMENTS, LP FundCUSIP 12674W109 · 2026Q2$4.4M0.00%
D. E. Shaw & Co., Inc. FundCUSIP 12674W109 · 2026Q2$282K0.00%

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.